Latest papers

Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system.

Treatment of resistant hypertension.

Review on pathophysiology and treatment of diabetic kidney disease.

Combined renin-angiotensin system-inhibition therapy: what really accounts for the additive benefits?

Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism susceptibility to essential hypertension in a south Indian Tamil population.

Evaluation of the contribution of renin angiotensin system polymorphisms to the risk of coronary artery disease among Tunisians.

Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.

Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.

[Pathophysiology of heart failure for clinicians].

[Impact of comorbidities for the treatment of heart failure].

[Medical management of chronic systolic heart failure].

Renin-angiotensin system blockade in older adults with chronic kidney disease: a review of the literature.

Combined rho kinase and renin-angiotensin system inhibition: a new therapeutic perspective for renal and cardiovascular remodeling.

Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages.

[Renal protection in the patients with idiopathic hypertensia: the possibilities of the combined blockade of the reninangiotensinaldosterone system].

Renin-angiotensin blockade is associated with increased mortality after vascular surgery.

Physiology of the (pro)renin receptor: Wnt of change?

How should we play our hand when holding an ACE?

Translational promise of the apelin--APJ system.

Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse.